Baclofen
FLEQSUVY, LYVISPAH, Lioresal (baclofen), OZOBAX
gamma-Aminobutyric Acid-ergic Agonist
NADAC/unit
$0.0330
No Shortage
Tier 1: 100.6%
PA Req: 0.3%
21 Manufacturers
65 ANDAs
INDICATIONS AND USAGE Baclofen tablets, USP are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and co....
vs. brand FLEQSUVY: Generic saves up to 100% per unit
Active Shortages
2025-04-23 Shortage reported, Upsher-Smith Laboratories, LLC
2025-04-23 Shortage reported, Upsher-Smith Laboratories, LLC
2025-04-23 Shortage reported, Upsher-Smith Laboratories, LLC
2025-04-23 Shortage reported, Upsher-Smith Laboratories, LLC
2025-04-23 Shortage reported, Upsher-Smith Laboratories, LLC
Market Intelligence
2025-12-24 Class II Recall: Golden State Medical Supply Inc.
Generic Manufacturers
AMNEAL PHARMACEUTICALS LLCANDAS 5 HOLDING LLCANI PHARMACEUTICALS INCAUROBINDO PHARMA LTDAZURITY PHARMACEUTICALS INCHIBROW HEALTHCARE PRIVATE LTDIVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USALANNETT CO INCMAIA PHARMACEUTICALS INCMANKIND PHARMA LTDMETACEL PHARMACEUTICALS LLCMICRO LABS LTDNORTHSTAR HEALTHCARE HOLDINGS LTDOXFORD PHARMACEUTICALS LLCPH HEALTH LTDPHARMOBEDIENT CONSULTING LLCPIRAMAL CRITICAL CARE INCREGCON HOLDINGS LLCRISING PHARMA HOLDINGS INCRUBICON RESEARCH LTDSOMERSET THERAPEUTICS LLCUNICHEM LABORATORIES LTDYILING PHARMACEUTICAL LTDZYDUS LIFESCIENCES GLOBAL FZE
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.